Insights into Amgen's Options Market Activity
Major investors, often referred to as "whales," are displaying a significantly positive outlook on Amgen. The recent activity in the options market paints an intriguing picture of investor confidence.
After examining Amgen's (NASDAQ: AMGN) options history, we've noted 10 key trades. Of these, around 40% of participants had bullish predictions, while another 40% took a bearish position.
In these trades, we identified 4 put options, which totaled $232,384, and 6 call options that amounted to $241,377. This combination of trades indicates a divide in market sentiment, showing cautious optimism among key traders.
Projected Price Target Analysis
By looking at the volume and open interest linked to these contracts, it's clear that large investors are targeting a price range between $280 and $340 for Amgen over the last three months. This suggests strategic preparation for possible fluctuations in Amgen's stock price.
Insights on Volume and Open Interest
Understanding the volume and open interest for Amgen's options can greatly enhance investment strategies. This data serves as a key indicator of liquidity and interest levels across different strike prices.
When analyzing Amgen’s trading activities in the past month, we uncover critical information about trends and patterns in the options market. Monitoring these variations helps investors gauge the overall market dynamics.
A 30-Day Overview of Call and Put Volume
Recognizing swing trading activities is essential for anticipating future stock price movements. Recent data on Amgen’s call and put options over the last month offers vital insights for investors looking to navigate these trends effectively.
Notable Options Activity
Here’s a summary of some significant options trades for AMGN:
| Symbol | PUT/CALL | Trade Type | Sentiment | Expiry Date | Ask Price | Bid Price | Trade Price | Strike Price | Total Trade Value | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGN | PUT | SWEEP | BEARISH | 10/18/24 | $5.30 | $4.70 | $4.70 | $330.00 | $133.90K | 462 | 330 |
| AMGN | CALL | SWEEP | BULLISH | 01/17/25 | $24.45 | $23.55 | $24.35 | $340.00 | $61.00K | 1.2K | 51 |
| AMGN | CALL | TRADE | BEARISH | 10/18/24 | $60.35 | $58.75 | $58.75 | $280.00 | $41.10K | 82 | 7 |
| AMGN | CALL | SWEEP | BEARISH | 12/20/24 | $27.45 | $26.60 | $26.60 | $330.00 | $39.90K | 1.1K | 1 |
| AMGN | CALL | SWEEP | BEARISH | 12/20/24 | $26.75 | $26.35 | $26.35 | $330.00 | $39.50K | 1.1K | 43 |
About Amgen
Amgen is a powerhouse in the biotechnology sector, dedicated to developing innovative human therapeutics. Its flagship products include red blood cell boosters like Epogen and Aranesp, as well as immune system enhancers Neupogen and Neulasta, along with treatments for inflammatory diseases such as Enbrel and Otezla. Amgen has also broadened its oncology offerings with significant launches like Vectibix for cancer and Prolia for osteoporosis.
Recent advancements feature therapies like Repatha for lowering cholesterol, Aimovig for treating migraines, and Lumakras for lung cancer management. The acquisition of Horizon has further bolstered Amgen's portfolio by adding treatments for rare diseases, such as Tepezza for thyroid eye disease, enhancing its already extensive biosimilar range.
Current Status of Amgen
- The trading volume currently sits at 158,874, and AMGN’s stock price has seen a slight decrease of -0.24%, now at $336.58.
- The Relative Strength Index (RSI) values indicate the stock may be approaching overbought conditions.
- Investors can expect the next earnings report in 36 days, which will provide important updates on the company's performance.
While options trading can be more unpredictable than regular stock trading, it also presents opportunities for significant returns. Seasoned options traders manage this risk by staying informed daily, carefully timing their trades, and using multiple indicators to effectively read market trends.
Frequently Asked Questions
What is the recent sentiment in the options market for Amgen?
The sentiment shows mixed feelings with large investors displaying an equal balance of bullish and bearish trades.
What price targets are whales targeting for Amgen?
Whales have recently focused on a price range between $280 and $340 for Amgen's stock in the past few months.
What recent therapies has Amgen introduced?
Amgen has introduced recent therapies including Repatha for cholesterol reduction, Aimovig for migraine relief, and Lumakras for lung cancer treatment.
How does volume and open interest help traders?
Volume and open interest offer valuable insights into liquidity and investor interest, playing a crucial role in shaping trading strategies and decisions.
What should investors consider about options trading?
Options trading is known for its higher risks but also for its potential for greater rewards, making education and sound risk management crucial for investors.
